SCHEMBL29488654

SCHEMBL29488654

N#Cc1nn(-c2cc(Cl)c(Cc3ccc(=O)n(-c4cccc(F)c4)n3)c(Cl)c2)c(=O)[nH]c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 14/20 0.54
THRB P10828 14/20 0.54
CYP2C8 P10632 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPT P10636 4/20 0.40
NPC1 O15118 3/20 0.40
HTT P42858 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
RAB9A P51151 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
BCAT1 P54687 1/20 0.40
ALDH1A1 P00352 2/20 0.33
OPRK1 P41145 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
LMNA P02545 1/20 0.33
KDM4E B2RXH2 1/20 0.33
S1PR4 O95977 1/20 0.33
HSP90AA1 P07900 1/20 0.33
S1PR1 P21453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29488645 0.92 THRA (0.57) THRATHRBCYP2C8CYP2C9MAPT
SCHEMBL29488650 0.90 THRA (0.55) THRATHRBCYP2C8CYP2C9MAPT
SCHEMBL29488642 0.89 THRA (0.52) THRATHRBKMT2A
SCHEMBL24820875 0.82 THRA (0.54) THRATHRBCYP2C8CYP2C9MAPT
SCHEMBL29488653 0.82 THRA (0.56) THRATHRBCYP2C8CYP2C9
SCHEMBL24821078 0.80 THRA (0.65) THRATHRBCYP2C8CYP2C9MAPT
SCHEMBL29488657 0.79 THRA (0.57) THRATHRBCYP2C8CYP2C9MAPT
SCHEMBL29488640 0.78 THRA (0.59) THRATHRBCYP2C8CYP2C9MAPT
SCHEMBL29488649 0.77 MAPT (0.40) THRBMAPTHTTADORA3LMNA
SCHEMBL24600250 0.76 THRA (0.50) THRATHRBCYP2C8CYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022068915-A1 6-OXO-1,6-DIHYDROPYRIDAZIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE 江苏恒瑞医药股份有限公司 2022-04-07 WO disclosed